Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of the Safety and Efficacy of Etanercept for the Therapy of Hydradenitis Suppurativa

NCT00329823 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT00329823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00329823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of the Safety and Efficacy of Etanercept for the Therapy of Hydradenitis Suppurativa
Lead sponsor
University of Athens
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
May 31, 2006
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa